ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 268 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $295,559 | -8.9% | 11,372 | +0.2% | 0.00% | 0.0% |
| Q1 2024 | $324,524 | -10.4% | 11,347 | -4.1% | 0.00% | -33.3% |
| Q4 2023 | $362,028 | +14.4% | 11,831 | +0.4% | 0.00% | 0.0% |
| Q3 2023 | $316,582 | -24.6% | 11,782 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $420,146 | +40.2% | 11,782 | -0.1% | 0.00% | +33.3% |
| Q1 2023 | $299,593 | +62576.4% | 11,795 | 0.0% | 0.00% | – |
| Q4 2022 | $478 | -99.9% | 11,795 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $390,000 | -3.5% | 11,795 | +2.7% | 0.00% | 0.0% |
| Q2 2022 | $404,000 | -23.9% | 11,482 | -0.5% | 0.00% | 0.0% |
| Q1 2022 | $531,000 | -30.7% | 11,544 | -0.1% | 0.00% | -33.3% |
| Q4 2021 | $766,000 | +7.3% | 11,557 | +1.0% | 0.01% | +20.0% |
| Q3 2021 | $714,000 | +7040.0% | 11,444 | +4897.4% | 0.01% | – |
| Q2 2020 | $10,000 | – | 229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |